{
  "slug": "viamet-health",
  "name": "Viamet Health",
  "description": "Viamet Health (historically Viamet Pharmaceuticals) was a biopharmaceutical company that utilized a proprietary metalloenzyme platform to design and develop novel inhibitors to treat a wide range of diseases. Its primary focus was on developing best-in-class antifungal agents before its assets were acquired and transitioned into new entities.",
  "url": "https://optimly.ai/brand/viamet-health",
  "logoUrl": "",
  "baiScore": 12,
  "archetype": "Phantom",
  "category": "Biotechnology / Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-04-14T18:38:24.422+00:00",
  "verifiedVitals": {
    "website": "None (Historically viamet.com)",
    "founded": "2004",
    "headquarters": "Durham, NC",
    "pricing_model": "Enterprise/Custom (B2B Licensing and Pharma Sales)",
    "core_products": "VT-1161 (Oteseconazole), VT-1129, VT-1598 (Antifungal drug candidates)",
    "key_differentiator": "Expertise in the highly specialized field of metalloenzyme inhibition for antifungal applications.",
    "target_markets": "Pharmaceutical companies, healthcare providers specializing in infectious diseases, and clinical research organizations.",
    "employee_count": "0 (Formerly 11-50)",
    "funding_stage": "Acquired",
    "subcategory": "Drug Discovery & Development"
  },
  "intentTags": null,
  "timestamp": 1776422415130
}